Appointments at Penn Pharma, Almac and Beardsworth – People on the move

By Nick Taylor

- Last updated on GMT

Related tags: Penn pharma, Management occupations, Vice president

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Penn Pharma, Almac and Beardsworth.

Patheon​ has hired Michael Lytton​ as executive vice president (EVP), corporate development and strategy, and general counsel. Lytton last worked at Biogen Idec and practiced law for 17 years.

Alison Martin ​has been named VP, international projects at Synexus​. Martin joins from INC Research where she worked as VP, clinical development, cardiovascular and endocrine.

Penn Pharma​ has appointed Mark Dean-Netscher​ as chief operating officer. Dean-Netscher has previously worked at Catalent Pharma Solutions and Reckitt Benckiser.

Todd Kole​ has joined Almac Clinical Technologies​ as vice president of clinical project services. Kole spent the past 12 years working at Clinphone and Perceptive Informatics.

Beardsworth ​has made two appointments to strengthen its oncology team. Evette Riegel​, formerly of Quintiles and Wyeth,​has been promoted to senior director, clinical operations and project management.

Also, Saishree Ramalingam ​joins the company as senior project manager. Ramalingam has previously worked at Pfizer, PharmaNet, Celgene, PRA International and more.

Cambridge Major Laboratories​ (CML​) has named Richard Proehl​ as VP of manufacturing. Proehl last worked at Coviden where he was responsible for the company’s largest active pharmaceutical ingredient (API) production plant.

Mark Wilkinson​, EVP and chief information officer at PPD​, has been appointed to serve on the USS North Carolina Battleship Commission​ by State Governor Beverly Perdue​. Wilkinson worked in the US military for 23 years and will now oversee the exhibit for World War II veterans.

BASi ​(Bioanalytical Systems Inc​) has made two hires. Peter White​, formerly of AstraZeneca,​is the new director of laboratory operations. Also, Bhavna Mistry has joined as senior scientist and principal investigator. Mistry also last worked at AstraZeneca.

Related topics: Markets & Regulations

Related news

Show more

Follow us


View more